SCHNEIDER EUGENE (EVP, Chf Clinical Develop Offc) sold 8.3% of their position (5.81K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $412.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/23/2026ACC: 0000874015-26-000152
Officer· EVP, Chf Clinical Develop Offc
Since Dec 2020
-5.81K
Net shares
Net seller
$412.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.81K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.81K
Price / share
$70.97
Trade value
$412.49K
% of position
8.3%
3/19/2026
69.70K→63.89K
Total
Net shares
−5.81K
Net value
-$412.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/19/2026 | S · Sale | −5.81K | $70.97 | $412.49K | 8.3% | 69.70K | 63.89K |
| Total | −5.81K | -$412.49K | ||||||
Derivative Transactions0
No derivative transactions reported